The Reimbursement Process in Three National Healthcare Systems: Variation in Time to Reimbursement of Pembrolizumab for Metastatic Non-Small Cell Lung Cancer
Journal of Pharmaceutical Policy and Practice（2023）
Key words
Pembrolizumab,Reimbursement,Lung cancer,Health policy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined